Top 5 Wellness Startup Investors in Taiwan in February 2025
A list of 5 angel investors and VC (Venture Capital) funds that invest in Wellness startups based in Taiwan. We rank investors based on the number of investments they made in Wellness companies from Taiwan. We update this investor list every month.Top 5 Wellness Startup Investors in Taiwan in February 2025
Investor | Wellness Taiwan investments |
---|---|
Panacea Venture | 1 |
Yan Jin | 1 |
Zero2IPO Ventures | 1 |
Sino Biopharmaceutical | 1 |
Suzhou Industrial Park Nankai Venture Capital | 1 |
Discover Panacea Venture - a global healthcare fund driving innovation in biotech. Transforming lives through investments. Explore our portfolio and strategy.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Seed
- China, United States, Taiwan
Portfolio highlights
- Chime Biologics — Chime Biologics, is a world-class experienced Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide a comprehensive solution supporting our customers from analytical and process transfer to early-stagebiopharmaceutical development through late-stage clinical and commercial drug substance and drug product manufacturing for Global Supply.
- Base Therapeutics — Best Bio is a developer of cell therapy products and gene therapy products.
- Eos BioInnovation — We are dedicated to incubating, launching, and building early-stage companies emerging from leading academic labs and research institutions in regenerative medicine.
Yan Jin has 15-year venture capital, investment banking, and corporate management experience covers more than 20 investment projects, involving consumer electronics, new materials, the Internet, and innovative services industries. Ms. Jin also serves as a leader of China’s Democratic National Construction Party, a political party separate from theCommunist Party of China. She is currently a legislative member of the Shenzhen Municipal Government. Ms. Jin is also a cofounder of Shenzhen Capital Group.
Show more
Investment focus
- Fitness, mHealth, Wellness
- Series A
- Taiwan
Portfolio highlights
- iFit — iFit (爱瘦身) is a website and mobile community that focuses on health and slimming services.iFit currently emphasizes on content, communities, and electronic commerce services. It plans on expanding its services into wearable equipment, application software, hardware services, and more. In March 2013, iFit gathered pictures and articles andpublished a book named Get Food not Fat, which was on the best-selling list once released. At the same time, IFit entered the group buying market.iFit was founded by Chen Yunru in June 2012. She started her business through a fan club by sharing her own experiences of losing weight. In less than a year her fan base reached more than 400,000. The official iFit website was set up in December 2012.
Zero2IPO Ventures is the venture investment arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO's vast network in China, Zero2IPO Ventures does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms ingrowth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors. We intend to leverage the extensive network that has been created by Zero2IPO Group, a leading venture capital and private equity market research and financial advisory company, to seek out potential investment opportunities and provide a strong value-add to our portfolio companies. Through its venture capital and private equity surveys, investment forums, training programs, and investment advisory services, Zero2IPO Group has developed a strong reputation in the China market for helping entrepreneurs connect with investors.
Show more
Investment focus
- E-Commerce, Internet, Education
- Series A, Series B, Angel
- China, India, Taiwan
Portfolio highlights
- AlpsenTek — AlpsenTek is a company engaged in the research and development of machine vision sensors and algorithms.
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
- Reistone Biopharma — Reistone Biopharma is a clinical stage biopharmaceutical company. It is focused on rapidly developing innovative medicines through global collaborations within Research and Development
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemicalmedicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
Show more
Investment focus
- Biotechnology, Health Care, Manufacturing
- Series D, Series B, Series E
- China, United States, Israel
Portfolio highlights
- Medlinker — Medical Alliance is a post of physician social service platform. Users are certified doctors working in the Medical Alliance, they can share knowledge, experience and insights with the other industry elite, to continue to provide high quality content for each other. Application provides a medical quiz, map that case, the anonymous social circlesand doctors and other functions, is committed to helping physicians groups, more convenient access to high-quality information from the industry
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
- Generon (Shanghai) Corporation — Generon (Shanghai) Corporation Ltd. is an integrated biotech company developing therapeutic biologics for patients world-wide. Their research & development center is located in Zhang Jiang High-Tech Park, Shanghai, China. their cGMP drug manufacturing facility is located in Economic-Technological Development Area, Beijing, China. Theirmission is “Innovating for Life” to develop innovative therapeutic biologics for global patients with unmet medical needs. They employ their proprietary, cutting-edge technology platforms to discover, develop and manufacture biologic therapeutics. They are focused on “best-in-class” and “first-in-class” recombinant therapeutic proteins to treat cancer, autoimmune and inflammatory diseases. They follow international quality standards for their product development and adhere to regulatory requirements of the CFDA, FDA and EMA. “Innovation and quality” are the soul of Generon in the generation of scientific data and in the processes of drug discovery, development and manufacturing.
Suzhou Industrial Park Nankai Venture Capital is engaged in venture capital business.
Show more
Investment focus
- Wellness, Health Care, Consumer Research
- Series A
- Taiwan
Portfolio highlights
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Investors by industry
Biotech
Energy
Health Care
Hardware
Gaming
Google
Artificial intelligence
Climate
Proptech
Community
FinTech
Consumer
Marketplace
Impact
EdTech
Sustainability
Venture Capital
Retail
Clean Energy
Finance
Education
Organic Food
Big Data
Web3
Food and Beverage
Financial Services
Payments
B2B
Real Estate
Publishing
Video Games
Beauty
Infrastructure
Photography
Medical
Social Network
Wellness
Music
Franchise
Mobile
Internet
Legal
Android
eSports
Construction
Sports
Enterprise Software
Social Media
Email
Art
Digital Media
Manufacturing
Local
Cannabis
Biotechnology
Recruiting
Fitness
Hospitality
Platforms
Mobile Advertising
Travel
Automotive
Wine And Spirits
Medical Device
Crowdfunding
Social
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Oil and Gas
Fashion
Theatre
Life Science
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
United Kingdom
Germany
United States
South Korea
Canada
Ireland
Australia
New Zealand
Oceania
LATAM
Africa
Asia
Japan
Saudi Arabia
China
Singapore
Spain
Vietnam
Faroe Islands
Barbados
Denmark
Chile
Ecuador
Ethiopia
Estonia
Hong Kong
France
Gibraltar
Costa Rica
Greece
Finland
Croatia
Egypt
Georgia
Algeria
Ghana
Bulgaria
Bermuda
Hungary
Czech Republic
Bahrain
Belize
Belgium
Belarus
Liechtenstein
Morocco
Liberia
Lebanon
Lithuania
Kuwait
Philippines
Mexico
Norway
Jersey
Mauritius
Israel
Malaysia
Peru
Malta
Myanmar
Italy
Mali
Nicaragua
Panama
Serbia
Ukraine
Uganda
Uzbekistan
Thailand
Portugal
Senegal
Sierra Leone
Venezuela
Russian Federation
Tajikistan
Rwanda
Zimbabwe
Zambia
Seychelles
Taiwan
Sweden
El Salvador
Tunisia
San Marino
Poland
Turkey
Puerto Rico
Uruguay
Slovenia
Togo
Tanzania
Dominican Republic
Iraq
Nigeria
Bahamas
Namibia
Azerbaijan
Iceland
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Pakistan
Albania
Bangladesh
Grenada
Romania
Jordan
Argentina
Armenia
South Africa
Middle East
Sri Lanka
Brazil
Indonesia
Europe
Qatar
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cameroon
Latvia
Oman
Cyprus
Austria
Switzerland
Marshall Islands
Colombia
Guatemala
Investors in Taiwan by industry
Financial Services
Cryptocurrency
Payments
Restaurants
Fashion
Food and Beverage
Medical Device
Medical
Transportation
Internet
Social Media
Mobile
Software
Automotive
Travel
Biotechnology
FinTech
Enterprise
Consumer
Health Care
Sustainability
Energy
Climate
Impact
SaaS
Marketplace
Hardware
Artificial intelligence
Gaming
Retail
Education
Blockchain
Big Data
Biotech
EdTech
Community
Mobile Apps
Wellness
Manufacturing
Web3
Agriculture (agtech)
Media (entertainment)
B2B